Short Interest in iShares Health Innovation Active ETF (NYSEARCA:BMED) Decreases By 39.2%

iShares Health Innovation Active ETF (NYSEARCA:BMED) saw a large decrease in short interest in July. As of July 15th, there was short interest totaling 1,114 shares, a decrease of 39.2% from the June 30th total of 1,831 shares. Based on an average daily volume of 3,283 shares, the short-interest ratio is presently 0.3 days. Currently, 0.3% of the company’s stock are short sold.

iShares Health Innovation Active ETF Stock Down 0.8%

Shares of BMED traded down $0.26 during mid-day trading on Friday, hitting $30.99. 155 shares of the company’s stock were exchanged, compared to its average volume of 3,542. iShares Health Innovation Active ETF has a 52 week low of $24.50 and a 52 week high of $32.19. The stock’s 50-day simple moving average is $29.74 and its 200-day simple moving average is $29.62. The firm has a market cap of $11.16 million, a price-to-earnings ratio of 24.91 and a beta of 0.73.

Institutional Trading of iShares Health Innovation Active ETF

A hedge fund recently bought a new stake in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. bought a new position in iShares Health Innovation Active ETF (NYSEARCA:BMED) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned approximately 3.63% of iShares Health Innovation Active ETF as of its most recent SEC filing.

iShares Health Innovation Active ETF Company Profile

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.